UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer

International journal of cancer, 2019-04, Vol.144 (8), p.2008-2019

2019

Link zum Volltext

Verfügbarkeit prüfen

ROS1 rearrangement testing: Is immunohistochemistry changing the horizon?

Cancer research, statistics, and treatment (Online), 2019-01, Vol.2 (1), p.66-68

2019

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation

Translational oncology, 2022-08, Vol.22, p.101461-101461, Article 101461

2022

Link zum Volltext

Verfügbarkeit prüfen

Liquid biopsy in lung cancer-hope or hype?

Cancer research, statistics, and treatment (Online), 2019-01, Vol.2 (2), p.221-223

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of Cutibacterium acnes with human thyroid cancer

Frontiers in endocrinology (Lausanne), 2023, Vol.14, p.1152514-1152514

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer

JCO global oncology, 2022-07, Vol.8 (8), p.e2200030-e2200030

2022

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre

Ecancermedicalscience, 2022-08, Vol.16

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification of EGFR mutations in type II papillary renal cell carcinoma

Cancer research, statistics, and treatment (Online), 2023, Vol.6 (3), p.457-460

2023

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine Kinase Inhibitor versus Physician Choice Chemotherapy in Second-Line Epidermal Growth Factor Receptor Mutation Non-Small Cell Lung Cancer: Post hoc Analysis of Randomized Control Trial

Indian journal of medical and paediatric oncology, 2018-10, Vol.39 (4), p.493-498

2018

Link zum Volltext

Verfügbarkeit prüfen

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons

F1000 research, 2015-01, Vol.4, p.160

2015

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary sarcomatoid carcinoma: Retrospective analysis from a single center

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21188-e21188

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations

Oncotarget, 2021-03, Vol.12 (6), p.578-588

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing as a tool for precision medicine

Cancer research, statistics, and treatment (Online), 2023, Vol.6 (4), p.589-592

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Lung cancer (Auckland), 2018-01, Vol.9, p.1-11

2018

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment

OncoTargets and therapy, 2017-01, Vol.10, p.2903-2908

2017

Link zum Volltext

Verfügbarkeit prüfen

Excellent response to erlotinib in breast carcinoma with rare EGFR mutation—a case report

Ecancermedicalscience, 2020-08, Vol.14

2020

Link zum Volltext

Verfügbarkeit prüfen

Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition

American journal of cancer research, 2023, Vol.13 (3), p.976-991

2023

Link zum Volltext

Verfügbarkeit prüfen

Optimization of Tissue Handling and Processing in the Era of Precision Medicine: A Practical Recommendation from a Multidisciplinary Panel of Indian Experts

Indian journal of medical and paediatric oncology, 2023-09

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

ESMO open, 2017, Vol.2 (1), p.e000168-e000168, Article e000168

2017

Link zum Volltext

Verfügbarkeit prüfen

Association Between CYP3A4 Polymorphisms, Trough Imatinib Plasma Concentration and Cytogenetic Response in Chronic Phase Chronic Myeloid Leukemia (CML-CP)

Blood, 2012-11, Vol.120 (21), p.3788-3788

2012

Link zum Volltext

Verfügbarkeit prüfen

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Lung cancer (Auckland), 2018-01, Vol.9, p.1

2018

Link zum Volltext

Verfügbarkeit prüfen

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect

F1000 research, 2016-03, Vol.4

2016

Link zum Volltext

Verfügbarkeit prüfen

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations

F1000 research, 2015, Vol.4, p.160-160

2015

Link zum Volltext

Verfügbarkeit prüfen

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons [version 1; peer review: 1 approved, 1 approved with reservations]

F1000 research, 2015, Vol.4, p.160

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(25)
Berichte
(2)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer

ROS1 rearrangement testing: Is immunohistochemistry changing the horizon?

Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation

Liquid biopsy in lung cancer-hope or hype?

Association of Cutibacterium acnes with human thyroid cancer

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer

Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre

Identification of EGFR mutations in type II papillary renal cell carcinoma

Understanding the Impact of Population and Cancer Type on Tumor Mutation Burden Scores: A Comprehensive Whole-Exome Study in Cancer Patients From India

Tyrosine Kinase Inhibitor versus Physician Choice Chemotherapy in Second-Line Epidermal Growth Factor Receptor Mutation Non-Small Cell Lung Cancer: Post hoc Analysis of Randomized Control Trial

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons

Pulmonary sarcomatoid carcinoma: Retrospective analysis from a single center

Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations

Identification of a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing as a tool for precision medicine

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment

Excellent response to erlotinib in breast carcinoma with rare EGFR mutation—a case report

Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition

Optimization of Tissue Handling and Processing in the Era of Precision Medicine: A Practical Recommendation from a Multidisciplinary Panel of Indian Experts

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Association Between CYP3A4 Polymorphisms, Trough Imatinib Plasma Concentration and Cytogenetic Response in Chronic Phase Chronic Myeloid Leukemia (CML-CP)

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons [version 1; peer review: 1 approved, 1 approved with reservations]

Suchergebnisse filtern